Nexalin Technology Stock Today

NXL Stock  USD 1.42  0.21  12.88%   

Performance

16 of 100

 
Weak
 
Strong
Solid

Odds Of Distress

Less than 43

 
High
 
Low
Below Average
Nexalin Technology is selling for 1.42 as of the 25th of April 2024. This is a -12.88 percent down since the beginning of the trading day. The stock's lowest day price was 1.42. Nexalin Technology has about a 43 percent probability of financial distress in the next few years of operation but had a somewhat solid performance during the last 90 days. Equity ratings for Nexalin Technology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
16th of September 2022
Category
Healthcare
Classification
Health Care
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company was incorporated in 2021 and is headquartered in Houston, Texas. Nexalin Technology operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 7.44 M outstanding shares of which 95.24 K shares are now shorted by investors with about 0.07 days to cover. More on Nexalin Technology

Moving against Nexalin Stock

  0.78UNH UnitedHealth Group Financial Report 12th of July 2024 PairCorr
  0.76HCAT Health Catalyst Financial Report 14th of May 2024 PairCorr
  0.75HSTM HealthStreamPairCorr
  0.72PRVA Privia Health Group Financial Report 2nd of May 2024 PairCorr
  0.71SINT SINTX TechnologiesPairCorr
  0.7BBLG Bone Biologics Corp Financial Report 20th of May 2024 PairCorr
  0.69NRC National Research CorpPairCorr

Nexalin Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nexalin Technology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nexalin Technology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, PresidentMark White
Thematic IdeaMedical Equipment (View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, SPASX All Technology, NASDAQ Health Care, Australia All Ordinaries, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Financial Strength
Based on the key measurements obtained from Nexalin Technology's financial statements, Nexalin Technology is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Nexalin Technology is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.0290.0305
Notably Down
Slightly volatile
Total Current Liabilities404 K425.3 K
Notably Down
Very volatile
Total Assets2.7 M3.6 M
Way Down
Slightly volatile
Total Current Assets2.6 M3.4 M
Way Down
Slightly volatile
Nexalin Technology's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Nexalin Technology's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Nexalin Technology's financial leverage. It provides some insight into what part of Nexalin Technology's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Nexalin Technology's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Nexalin Technology deploys its capital and how much of that capital is borrowed.
Liquidity
Nexalin Technology cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 4.46 K in debt. Nexalin Technology has a current ratio of 0.2, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Nexalin Technology until it has trouble settling it off, either with new capital or with free cash flow. So, Nexalin Technology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nexalin Technology sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nexalin to invest in growth at high rates of return. When we think about Nexalin Technology's use of debt, we should always consider it together with cash and equity.

Change In Working Capital

(730,419)
Nexalin Technology (NXL) is traded on NASDAQ Exchange in USA. It is located in 1776 Yorktown, Houston, TX, United States, 77056 and employs 6 people. Nexalin Technology is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 12.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nexalin Technology's market, we take the total number of its shares issued and multiply it by Nexalin Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nexalin Technology runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 7.44 M outstanding shares of which 95.24 K shares are now shorted by investors with about 0.07 days to cover. Nexalin Technology has about 291.33 K in cash with (3.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check Nexalin Technology Probability Of Bankruptcy
Ownership Allocation
Nexalin Technology holds a total of 7.44 Million outstanding shares. Nexalin Technology holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Nexalin Ownership Details

Nexalin Stock Price Odds Analysis

Proceeding from a normal probability distribution, the odds of Nexalin Technology jumping above the current price in 90 days from now is about 22.18%. The Nexalin Technology probability density function shows the probability of Nexalin Technology stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 2.7705. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Nexalin Technology will likely underperform. In addition to that, nexalin Technology has an alpha of 2.8234, implying that it can generate a 2.82 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 1.42HorizonTargetOdds Above 1.42
77.78%90 days
 1.42 
22.18%
Based on a normal probability distribution, the odds of Nexalin Technology to move above the current price in 90 days from now is about 22.18 (This Nexalin Technology probability density function shows the probability of Nexalin Stock to fall within a particular range of prices over 90 days) .

Nexalin Technology Historical Income Statement

Nexalin Technology Income Statement is one of the three primary financial statements used for reporting Nexalin's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Nexalin Technology revenue and expense. Nexalin Technology Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Nexalin Technology's Selling And Marketing Expenses is quite stable compared to the past year. Cost Of Revenue is expected to rise to about 1.5 M this year, although the value of Interest Expense is projected to rise to (36.9 K). View More Fundamentals

Nexalin Stock Against Markets

Picking the right benchmark for Nexalin Technology stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Nexalin Technology stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Nexalin Technology is critical whether you are bullish or bearish towards Nexalin Technology at a given time. Please also check how Nexalin Technology's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Nexalin Technology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Nexalin Technology Corporate Management

Elected by the shareholders, the Nexalin Technology's board of directors comprises two types of representatives: Nexalin Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nexalin. The board's role is to monitor Nexalin Technology's management team and ensure that shareholders' interests are well served. Nexalin Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nexalin Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Marilyn ElsonChief OfficerProfile
Joel BradusDirector MarketingProfile
David MDChief DirectorProfile
Michael NketiahRegulatory QualityProfile

How to buy Nexalin Stock?

Before investing in Nexalin Technology, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Nexalin Technology. To buy Nexalin Technology stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Nexalin Technology. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Nexalin Technology stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Nexalin Technology stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Nexalin Technology stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Nexalin Technology, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Nexalin Stock please use our How to Invest in Nexalin Technology guide.

Already Invested in Nexalin Technology?

The danger of trading Nexalin Technology is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Nexalin Technology is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Nexalin Technology. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Nexalin Technology is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for Nexalin Stock analysis

When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Nexalin Technology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.63)
Revenue Per Share
0.015
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.64)
Return On Equity
(1.07)
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.